Wealth Alliance Advisory Group, LLC Bristol Myers Squibb CO Transaction History
Wealth Alliance Advisory Group, LLC
- $482 Million
- Q3 2025
A detailed history of Wealth Alliance Advisory Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealth Alliance Advisory Group, LLC holds 14,847 shares of BMY stock, worth $694,988. This represents 0.14% of its overall portfolio holdings.
Number of Shares
14,847
Previous 17,239
13.88%
Holding current value
$694,988
Previous $797,000
16.06%
% of portfolio
0.14%
Previous 0.17%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,684Shares Held
1.58BCall Options Held
28.2MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...